Sun Pharma launches dry eye treatment product in Canada

The product is the first dry eye treatment available in Canada that is delivered with nanomicellar (NCELL) technology, which improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration, Sun Pharma said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3KNMafO
via IFTTT